IPOs & Markets
The flat rejection indicates HKEX boss Charles Li is unlikely to win LSE board round with an improved offer.
Asia Pacific represents around 16% of EQT's portfolio.
EQT is putting the finishing touches to the deal, which would value the unit at up to $10 billion.
The deal could potentially be worth up 20 billion euros ($22.73 billion).
The two other bidding groups are led by Australian investment firm Macquarie and U.S. infrastructure fund I Squared Capital respectively.
The moves coincide with a shift toward renewable energy sources that is driving a wave of consolidation among traditional utilities and power companie
Godiva's Japanese business has revenue of around $350 million a year and is likely to appeal to companies or investors with experience in Japan.
The three consumer goods giants are seen as frontrunners for a business that offers a significant footprint in a fast-growing emerging market.
The main asset on the block in the sale is GSK's 72.5% stake in its Indian subsidiary GlaxoSmithKline Consumer Healthcare, which is famous for Horlic
PIF's reluctance will add to the pressure on Musk to produce details of his financing plan.
© Copyright DEALSTREETASIA 2014-2019 All rights reserved.
Forgot your password?
We will never share your information with third parties.
Already have an account? Sign in here
If you don’t already have an account click the button below to create your account.
Unlock your competitive advantage in a
rapidly evolving landscape. Our packages
come with exclusive access to archive
content, data, discount on summit tickets & more.
Be a part of our growing community now.